We first assessed HN expression by immunofluorescence in the human GBM cell line U251-MG, as well as in cell cultures derived from a GBM biopsy (wtIDH glioma, G09) [21] incubated with or without cisplatin. Here, MT-RNR2 is linked to central nervous system cancer.